Regeneron requests emergency approval for antibody treatment taken by Trump; stock rises 4% in pre-market

Regeneron's stock price rose over 4% in pre-market trade Thursday.

from Health and Science https://ift.tt/3nr7jRb
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH